Bilirubin—A Possible Prognostic Mortality Marker for Patients with ECLS
Authors:
- Sebastian BunteSBSebastian Bunte
- Roland WalzRWRoland Walz
- Julia MerkelJMJulia Merkel
- Carolin TorregrozaCTCarolin Torregroza
- Sebastian RothSRSebastian Roth
- Giovanna Lurati BuseGBGiovanna Lurati Buse
- Hannan DalyanogluHDHannan Dalyanoglu
- Payam AkhyariPayam Akhyari
- Artur LichtenbergALArtur Lichtenberg
- Markus W. HollmannMHMarkus W. Hollmann
- Hug AubinHAHug Aubin
- Ragnar HuhnRHRagnar Huhn
Open Access
- 3 June 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (6) , 1727
Abstract
Extracorporeal life support (ECLS) is a promising therapeutic option for patients with refractory cardiogenic shock. However, as the mortality rate still remains high, there is a need for early outcome parameters reflecting therapy success or futility. Therefore, we investigated whether liver enzyme levels could serve as prognostic mortality markers for patients with ECLS. The present study is a retrospective single-center cohort study. Adult patients >18 years of age who received ECLS therapy between 2011 and 2018 were included. Bilirubin, glutamic-oxaloacetic transaminase (GOT), and glutamic-pyruvic-transaminase (GPT) serum levels were analyzed at day 5 after the start of the ECLS therapy. The primary endpoint of this study was all-cause in-hospital mortality. A total of 438 patients received ECLS during the observation period. Based on the inclusion criteria, 298 patients were selected for the statistical analysis. The overall mortality rate was 42.6% (n = 127). The area under the curve (AUC) in the receiver operating characteristic curve (ROC) for bilirubin on day 5 was 0.72 (95% confidence interval (CI): 0.66–0.78). Cox regression with multivariable adjustment revealed a significant association between bilirubin on day 5 and mortality, with a hazard ratio (HR) of 2.24 (95% CI: 1.53–3.30). Based on the results of this study, an increase in serum bilirubin on day 5 of ECLS therapy correlates independently with mortality.Keywords
This publication has 20 references indexed in Scilit:
- Liver function predicts survival in patients undergoing extracorporeal membrane oxygenation following cardiovascular surgeryCritical Care, 2016
- Bleeding, Transfusion, and Mortality on Extracorporeal Life Support: ECLS Working Group on Thrombosis and HemostasisThe Annals of Thoracic Surgery, 2016
- Long-term survival of adults with cardiogenic shock after venoarterial extracorporeal membrane oxygenationJournal of Critical Care, 2015
- Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-scoreEuropean Heart Journal, 2015
- Complications of Extracorporeal Membrane Oxygenation for Treatment of Cardiogenic Shock and Cardiac Arrest: A Meta-Analysis of 1,866 Adult PatientsThe Annals of Thoracic Surgery, 2014
- Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysisThe Lancet, 2008
- Factors influencing survival after in-hospital cardiopulmonary resuscitationResuscitation, 2005
- Back from Irreversibility: Extracorporeal Life Support for Prolonged Cardiac ArrestThe Annals of Thoracic Surgery, 2005
- Etiology and Outcome of Acute Liver Failure: Experience from a Liver Transplantation Centre in MontrealCanadian Journal of Gastroenterology and Hepatology, 2002
- Cardiac ResuscitationNew England Journal of Medicine, 2001